Clinical Trials
4
Active:0
Completed:2
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Clinical Evaluation of OSNA Breast Cancer System to Extensive Frozen Section Histopathology
Completed
- Conditions
- Breast NeoplasmsBreast Diseases
- First Posted Date
- 2011-06-08
- Last Posted Date
- 2011-06-08
- Lead Sponsor
- Sysmex America, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT01368744
- Locations
- 🇮🇹
University of Milan School of Medicine, Milan, Italy
Clinical Evaluation of OSNA Breast Cancer System in Breast Cancer Patients Receiving Neoadjuvant Therapy
Terminated
- Conditions
- Breast NeoplasmsBreast Diseases
- First Posted Date
- 2010-06-09
- Last Posted Date
- 2011-06-07
- Lead Sponsor
- Sysmex America, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT01140776
- Locations
- 🇺🇸
Arizona Cancer Center, Tucson, Arizona, United States
🇺🇸University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Clinical Evaluation of Tissue Sampling Bias in Histologic Evaluation of Sentinel Lymph Nodes in Breast Cancer
- Conditions
- Breast DiseasesBreast Neoplasms
- First Posted Date
- 2010-06-09
- Last Posted Date
- 2010-08-30
- Lead Sponsor
- Sysmex America, Inc.
- Target Recruit Count
- 75
- Registration Number
- NCT01140763
- Locations
- 🇺🇸
Breast Care Specialist, PC, Allentown, Pennsylvania, United States
Clinical Evaluation of OSNA Breast Cancer System to Test Sentinel Lymph Nodes From Patients With Breast Cancer
Completed
- Conditions
- Breast NeoplasmsBreast Diseases
- First Posted Date
- 2010-06-03
- Last Posted Date
- 2010-06-03
- Lead Sponsor
- Sysmex America, Inc.
- Target Recruit Count
- 496
- Registration Number
- NCT01136369
- Locations
- 🇺🇸
John Wayne Cancer Institute, Santa Monica, California, United States
🇺🇸WellStar Health Systems, Marietta, Georgia, United States
🇺🇸Washington University Medical School, Saint Louis, Missouri, United States
News
No news found